Form 4: Talphera Director Granted Equity Compensation

Talphera, Inc. director Marina Bozilenko received 4,267 restricted stock units and 25,600 stock options as equity compensation.

Summary

• Marina Bozilenko, a Director of Talphera, Inc. (TLPH), was granted equity compensation.
• The compensation includes 4,267 restricted stock units (RSUs) and 25,600 stock options.
• Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• The stock options have an exercise price of $1.14 per share.
• Both the RSUs and stock options were granted on October 23, 2025, with a grant price of $0.
• All granted RSUs and stock options will vest 100% on the first anniversary of the grant date, subject to continuous service to the company.
• Following these transactions, Marina Bozilenko beneficially owns 9,047 shares of common stock (from RSUs) and 25,600 stock options.

Sentiment

Score: 7

Explanation: The grant of equity compensation to a director is generally a positive signal, as it aligns management's interests with shareholders. However, it's a routine compensation event and not indicative of significant operational or financial performance changes.

Positives

• Equity grants align the director's interests with those of shareholders, incentivizing long-term company performance.
• The grants represent a commitment from the company to retain and compensate key leadership.

Negatives

• The value of the equity compensation is contingent on the company's future stock performance and the director's continuous service.
• There is no immediate cash benefit to the director from these grants.

Risks

• The value of the restricted stock units and stock options could decrease if Talphera's stock price declines.
• Vesting is subject to continuous service, meaning the director must remain with the company for the equity to fully vest.

Future Outlook

The director's future beneficial ownership of these equity instruments is contingent upon continuous service to the company, with full vesting expected on the first anniversary of the grant date, October 23, 2026.

Industry Context

This equity grant is a standard practice in the biotechnology and pharmaceutical industries to compensate and incentivize directors, aligning their long-term interests with company performance and shareholder value creation.

Related Party Transactions

• The grant of restricted stock units and stock options to Marina Bozilenko, a Director of Talphera, Inc., constitutes a related party transaction as it involves compensation between the company and a member of its board.

Stakeholder Impact

• Shareholders: Interests are aligned with the director through equity compensation, potentially leading to better long-term performance.
• Employees: May view this as a standard compensation practice for leadership.

Next Steps

• Continued service by the director to ensure vesting of the granted equity.
• Vesting of 4,267 restricted stock units and 25,600 stock options on October 23, 2026.

Key Dates

Keywords

Talphera, TLPH, Form 4, SEC filing, equity compensation, restricted stock units, RSUs, stock options, director compensation, insider transaction, beneficial ownership